The discovery of new calcium and phosphate metabolism regulators, such as the phosphaturic hormone fibroblast growth factor 23 (FGF23), together with the elucidation of the underlying genetic defects in many hereditary forms of rickets and the availability of comprehensive genetic testing has improved our understanding of the underlying pathophysiology and revolutionized its diagnosis. This evidence concerns the gene FGF23 and rickets.